Latest From Biotech Now

The Future of Renewable Chemicals

lab_tech02

On Monday, the BIO Pacific Rim Summit on Industrial Biotechnology & Bioenergy, heard from three companies and their perspectives on the future of renewable chemicals. Carolyn Fritz, Allylix, led the session and provided great insight to the similarities and differences among DuPont, BASF, and Green Biologics throughout the discussion. Markus Pompejus provided BASF’s perspective on biobased chemicals. BASF understands that sustainability is a goal of many of their customers including the brand owners who are Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

House Committee Examines GM Food Ingredients and FDA Regulation

admin-ajax copy

It was a big day for agricultural biotechnology in our nation’s capital. The House Energy and Commerce Health Subcommittee held a hearing today on the labeling of genetically modified foods and specifically looked at proposed legislation aimed at remedying the contentious debate. The Safe and Affordable Food Act, HR 4432, would eliminate consumer confusion created by a state-by-state patchwork of labeling laws, advance food safety, inform consumers and provide consistency in food labeling. The bill: reaffirms Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Now What is Patentable?

lab_tech

On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the legal, policy and business implications of the Myriad decision, the United States Patent and Trademark Office (PTO) guidance on patentable subject matter under Myriad issued earlier this year, and the revised Myriad guidance expected from the PTO later this year. The Patent Copyright Clause, United States Constitution, Article 1, Section 8: To promote the progress of science and useful arts, by Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Wall Street Journal Highlights Promising Gene Therapy Advances

Jim Greenwood

Yesterday, bluebird bio reported some very uplifting news at the annual meeting of the American Society of Hematology. Two patients with beta-thalassemia, a genetic disorder which normally requires regular blood transfusions, have been able to forgo transfusions for at least five months following a gene therapy treatment from bluebird. The Wall Street Journal’s Ron Winslow reports: Bluebird bio’s treatment involves extracting blood stem cells from a patient, treating them with a functioning version of the defective Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Recap: “Optimizing Waste Feedstocks to Advance the Bioeconomy”

Pac_Rim115x75

On Monday, December 8, BIO’s Pacific Rim Summit on Industrial Biotechnology and Bioenergy held a Track Session titled “Optimizing Waste Feedstocks to Advance the Bioeconomy.”  This session was one of the many unique sessions included in the Feedstock Production and Utilization Track.  Tim Cesarek of Enerkem moderated the session and panelists included Tim Hitchman, DSM, Mohamed Leila, McGill, and Brittany Syz, Oberon Fuels, Inc. Tim Cesarek, head of business development at Enerkem spoke on how the company’s plant in Edmonton, Alberta Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,